Oculis Holding AG (OCS)

Oculis Holding AG (OCS) is a healthcare company (biotechnology) based in Switzerland. The share price is $7.51, down 1.57% on the day, which values the company at $418.42M. Price as of 18 Nov 2026, 12:50 UTC, from Yahoo Finance.

Key facts

Share price
$7.51−1.57% today
Market value
$418.42M
200-week average
$15.3051% below
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Oculis Holding AG in more detail

OCS trades at -4.2× next year's expected earnings, 446.6× sales. It sits 51% below its 200-week average of $15.30.

In its favour: More cash than debt. Worth checking: Thin interest cover; Debt is growing faster than cash flow.

Oculis Holding AG (OCS): questions and answers

What is Oculis Holding AG's market cap?

Oculis Holding AG is valued at $418.42M at a share price of $7.51.

Is OCS above its 200-week moving average?

No. OCS is 50.9% below its 200-week average of $15.30. Long-term investors watch that line because strong companies rarely trade below it for long.

Does OCS pay a dividend?

Oculis Holding AG does not currently pay a regular dividend.

Cite this page

Funkfolio, “Oculis Holding AG (OCS) stock: price, valuation and fundamentals”, data as of 18 November 2026. https://funkfolio.com/stock/OCS

Underlying data: Yahoo Finance; company filings with the SEC.